Hospitals in Four States Select BIO-key & Biometric Authentication to Enhance Security, Workflow

WALL, N.J. - Jan. 6, 2015 - PRLog -- BIO-key International, Inc. , a leader in fingerprint biometric identification technologies for hospitals, clinics and private medical practices, reported that the company has received initial purchase orders from hospitals in NY, OH, KY and CA, with a combined value of $130,000. These initial contracts will represent over $400,000 in revenue in 2015 as full roll-outs are expected beginning in the first quarter and throughout the year. BIO-key will provide fingerprint authentication solutions to these hospitals and others, to raise the level of security and convenience for healthcare providers as they update patient records and process Electronic Prescription of Controlled Substances (EPCS). BIO-key’s fingerprint authentication solutions support their Meaningful Use roadmaps and meet compliance guidelines from the U.S. Drug Enforcement Agency (DEA) and respective State Boards of Pharmacy. Fingerprint authentication has become the preferred authentication option in Healthcare for meeting Meaningful Use, EPCS, I-STOP, CPOE and other requirements.

Since entering the healthcare market with George Washington University Hospital in 2006, BIO-key’s established a respected reputation and delivered expertise to hospital IT executives as well as EHR and security framework vendors. By partnering with leading EHR platform providers such as Epic and Allscripts, Single Sign-on provider HealthCast and the world’s top security providers IBM and CA, BIO-key offers our customers stronger options to solve their security, workflow and compliance challenges.

“These hospital deployments are the beginning results of our strategic efforts in the North American Healthcare Market, where we enjoy technology mandates, high barriers to competition, a well-recognized and respected brand, along with many marquee customers and partners. We’re finding that our hospital customer CIO’s face three primary challenges; security, workflow and compliance” stated Mike DePasquale, BIO-key’s Chairman & CEO. “We deliver measurable improvements in each area and are seeing a noticeable increase in healthcare demand, measured in both opportunity solicitations and gross monetary value.”

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key’s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world’s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.  BIO-key’s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement

Certain statements contained in this press release and in other public statements by the Company and Company officers include or may contain certain forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “will,” “may,” “future,” “plan,” “intend” and “expect” and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; delays in the development of products and statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.